Kim Seungjin, Ye Dae-Yeol, Lim Hyun Gyu, Noh Myung Hyun, Yang Jae-Seong, Jung Gyoo Yeol
Department of Chemical Engineering, Pohang University of Science and Technology, 77 Cheongam-Ro, Nam-Gu, Pohang, 37673, Gyeongbuk, Korea.
Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-Ro, Michuhol-Gu, Incheon, 22212, Korea.
Microb Cell Fact. 2025 May 22;24(1):120. doi: 10.1186/s12934-025-02739-4.
Cadaverine, displaying potential in medicine, agriculture and polyamide production, is biologically produced through L-lysine decarboxylation. Considering the potential of the polyamide market, its biological production has been focused on with following diverse efforts to improve the production. In Escherichia coli, lysine decarboxylase exists in two forms: CadA and LdcC, and it is known that CadA exhibits superior catalytic activity compared to LdcC. Despite its potential, cadaverine production is limited due to increased intracellular pH, which destabilizes the decameric structure of CadA and inhibits its activity.
In this study, based on the structural analysis, a chimeric CadA enzyme, CL2, was engineered by replacing its pH-sensitive region with a structurally stable counterpart derived from LdcC. The resulting BLCL2 strain with CL2 produced 1.12 g/L of cadaverine-1.96 times higher than BLC strain with the wild type CadA in flask culture. Compared to the wild type CadA, structural modifications enhanced pH stability and improved the affinity of CadA toward pyridoxal 5-phosphate (PLP), its cofactor.
This study developed the improved strains for cadaverine production by creating the new enzyme, which is validated by enhanced amount of cadaverine. In addition, the segmental swapping guided by structure analysis was exhibited as the one of effective method in protein engineering strategies. These advancements offer a promising approach to optimizing cadaverine biosynthesis for industrial applications.
尸胺在医学、农业和聚酰胺生产中具有潜在应用价值,可通过L-赖氨酸脱羧作用生物合成。考虑到聚酰胺市场的潜力,其生物生产一直是研究重点,人们通过多种努力来提高产量。在大肠杆菌中,赖氨酸脱羧酶有两种形式:CadA和LdcC,已知CadA的催化活性优于LdcC。尽管尸胺有潜在价值,但由于细胞内pH值升高,CadA的十聚体结构不稳定并抑制其活性,导致尸胺产量受限。
在本研究中,基于结构分析,通过用源自LdcC的结构稳定区域替换其pH敏感区域,构建了嵌合CadA酶CL2。在摇瓶培养中,表达CL2的BLCL2菌株产生了1.12 g/L的尸胺,比表达野生型CadA的BLC菌株高1.96倍。与野生型CadA相比,结构修饰增强了pH稳定性,并提高了CadA对其辅因子磷酸吡哆醛(PLP)的亲和力。
本研究通过构建新酶开发了用于尸胺生产的改良菌株,尸胺产量的提高验证了这一点。此外,结构分析指导的片段交换被证明是蛋白质工程策略中的有效方法之一。这些进展为优化尸胺生物合成以用于工业应用提供了一种有前景的方法。